Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
Autor: | Federica Agosta, Javier Arbizu, Peter J. Nestor, Alexander Drzezga, Stefania Orini, Daniele Altomare, Cristina Festari, Femke H. Bouwman, Flavio Nobili, Koen Van Laere, Zuzana Walker, Marina Boccardi |
---|---|
Přispěvatelé: | Nobili, Flavio, Festari, Cristina, Altomare, Daniele, Agosta, Federica, Orini, Stefania, Van Laere, Koen, Arbizu, Javier, Bouwman, Femke, Drzezga, Alexander, Nestor, Peter, Walker, Zuzana, Boccardi, Marina |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Radiology
Nuclear Medicine and Imaging medicine.medical_specialty diagnostic imaging [Neurodegenerative Diseases] MEDLINE Sensitivity and Specificity Lower limit 030218 nuclear medicine & medical imaging Diagnosis Differential 03 medical and health sciences 0302 clinical medicine Fluorodeoxyglucose F18 Semi-quantitative assessment Medicine Dementia Humans Radiology Nuclear Medicine and imaging In patient Medical physics ddc:610 diagnostic imaging [Dementia] computer.programming_language Neurodegenerative Disease business.industry Brain FDG-PET Dementia Neurodegenerative diseases Semi-quantitative assessment Visual reading Neurodegenerative Diseases General Medicine Dementia/diagnostic imaging medicine.disease Neurodegenerative Diseases/diagnostic imaging Quality of evidence Positron-Emission Tomography ddc:618.97 Visual reading Brain FDG-PET Differential diagnosis business computer 030217 neurology & neurosurgery Delphi Human |
Zdroj: | European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1557-1566 For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders 2018, ' Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, pp. 1557-1566 . https://doi.org/10.1007/s00259-018-4030-3 European journal of nuclear medicine and molecular imaging 45(9), 1557-1566 (2018). doi:10.1007/s00259-018-4030-3 |
ISSN: | 1619-7070 |
DOI: | 10.1007/s00259-018-4030-3 |
Popis: | PURPOSE: To review literature until November 2015 and reach a consensus on whether automatic semi-quantification of brain FDG-PET is useful in the clinical setting for neurodegenerative disorders. METHODS: A literature search was conducted in Medline, Embase, and Google Scholar. Papers were selected with a lower limit of 30 patients (no limits with autopsy confirmation). Consensus recommendations were developed through a Delphi procedure, based on the expertise of panelists, who were also informed about the availability and quality of evidence, assessed by an independent methodology team. RESULTS: Critical outcomes were available in nine among the 17 papers initially selected. Only three papers performed a direct comparison between visual and automated assessment and quantified the incremental value provided by the latter. Sensitivity between visual and automatic analysis is similar but automatic assessment generally improves specificity and marginally accuracy. Also, automated assessment increases diagnostic confidence. As expected, performance of visual analysis is reported to depend on the expertise of readers. CONCLUSIONS: Tools for semi-quantitative evaluation are recommended to assist the nuclear medicine physician in reporting brain FDG-PET pattern in neurodegenerative conditions. However, heterogeneity, complexity, and drawbacks of these tools should be known by users to avoid misinterpretation. Head-to-head comparisons and an effort to harmonize procedures are encouraged. ispartof: European Journal Of Nuclear Medicine And Molecular Imaging vol:45 issue:9 pages:1557-1566 ispartof: location:Germany status: published |
Databáze: | OpenAIRE |
Externí odkaz: |